So long, Shulkin? Trump eyes Cleveland Clinic’s Cosgrove as VA sec

Conflicting news reports swirl around David Shulkin, Veterans Affairs Secretary to President Donald Trump who has faced criticism for excessive travel spending and heavy-handed approaches to staffing decisions.

On Monday, March 26, the AP released a story citing White House sources who expected Shulkin to be removed in the coming days. One unnamed source guessed the VA Secretary had a 50-50 chance of surviving the next few days. By the end of the day, contradicting reports emerged. Politico published a story that President Trump had confidence in Shulkin “at this time”—a phrase that could be considered ominous in an administration known for its turnover.

Additional reports state former Cleveland Clinic CEO Tony Cosgrove is a leading figure to replace Shulkin, should be he ousted. According to Cleveland.com, he has not had discussions with the White House about such a move.

He has been linked to the VA before—with Barack Obama offering him the job in 2014 and Trump discussing it in 2017. Cosgrove turned down the opportunity both times.

"Dr. Cosgrove was honored to be considered for the role, but withdrew his name because of commitments he has yet to fulfill here at Cleveland Clinic," Clinic spokeswoman Eileen Sheil said after Cosgrove stepped out of the running in 2017. "It was a difficult decision that he did not take lightly. As a Vietnam Veteran, he understands the importance of this role."

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”